Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04750785 · ClinicalTrials.gov registry record
A Study to Assess Choroideremia (CHM) Health Outcomes
A clinical trial, sponsored by Biogen.
- Completed
- Registry status
- 46
- Enrollment target
NCT04750785 is a clinical trial that has completed, run by Biogen. The registered enrollment target is 46 participants.
The verdict
NCT04750785 has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The primary objectives of this study are to describe disease progression and severity by age in participants with CHM, to assess health-related quality-of-life, resource utilization and work productivity, and to assess quality-of-life, work productivity, and impact on daily activities in caregivers of participants with CHM at different stages of disease progression.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2020-12-15 |
| Est. Completion | 2021-09-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04750785
The ClinicalTrials.gov registry entry for NCT04750785 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT04750785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04750785 about?
NCT04750785 is a clinical study titled "A Study to Assess Choroideremia (CHM) Health Outcomes". The primary objectives of this study are to describe disease progression and severity by age in participants with CHM, to assess health-related quality-of-life, resource utilization and work productivity, and to assess quality-of-life, work productivity, and impact on daily activities in caregivers ...
What is the current status of trial NCT04750785?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2020-12-15. Estimated completion is 2021-09-27.
What interventions are being tested in trial NCT04750785?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT04750785?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.